Community Anticoagulation Services - Bromley

This is a Prior Information Notice. NHS South East London (NHS SEL ICB, hereafter referred to as "The Authority") invites Expressions of Interest (EoIs) and completion of a Market Engagement Questionnaire from all suitable providers, who are capable of delivering the required Community Anticoagulation services in Bromley or who wish to provide feedback on the Authority's proposals. NHS South East London - Bromley borough - has a community anticoagulation service which is currently delivered via 6 clinics and home visiting service. The service includes: • Initiation of anticoagulation treatment: both Direct Oral Anti-Coagulants (DOAC) and Warfarin (majority of new referrals are initiated on DOAC) • Around 22 new referrals per month, accepting from primary and secondary care • Monitoring of warfarin patients (700 under the service, around 1030 appointments per month) • Home visiting to housebound patients eligible for the community service (around 320 visits per month) • Undertaking measures to bring patients back into therapeutic INR range, however onward referral to secondary care is facilitated when necessary. • Undertaking switches between Direct Oral Anti-Coagulants (DOAC) as appropriate during initiation period. • Service delivered by pharmacist leads and Independent Prescribers (IPs). Clinical supervision is outsourced to a hospital-based consultant (not based in Bromley, but within SEL). This contract is due to expire on 31/03/2023 and NHS South East London is seeking expressions of interest and feedback on proposals from capable suppliers ahead of launching a procurement process to determine the service provider for the services from 01/04/2023. The annual contract value is expected to be between £320,000 and £370,000. This leaves a maximum 3-year contract value of £1,110,000 and a maximum 5-year contract value of £1,850,000.